| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 5647691 | Journal of the American Academy of Dermatology | 2017 | 11 Pages |
Abstract
There is a significant risk of development of pigmentary changes during treatment with targeted anticancer therapies. Appropriate counseling and management are critical to minimize psychosocial impairment and deterioration in quality of life.
Keywords
Related Topics
Health Sciences
Medicine and Dentistry
Dermatology
Authors
Julia MD, Viswanath R. MD, Shenhong MD, PhD, Vincent MD, Mario E. MD,